Company
United StatesPublic company, NYSE: BLCOBausch & Lomb Inc (NYSE: BLCO), Saint Louis, MO – FDA Inspections
Inspection records and compliance data for Bausch & Lomb Inc in Saint Louis, Missouri. 5 FDA inspections on record, last inspected October 08, 2019. Publicly traded as NYSE: BLCO.
Company Profile
This profile covers Bausch & Lomb Inc based in Saint Louis, Missouri, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 4
- Form 483s
- 0
- Warning letters
- 0
First inspected May 17, 2012. Last inspected October 8, 2019.
Most cited issue areas
- Investigation of device failures1 inspection
- Lack of or inadequate complaint procedures1 inspection
- Nonconforming product control1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 8, 2019 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1107226 |
| June 10, 2016 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 978030 |
| March 15, 2013 | NAI | Medical Devices & Rad Health · Compliance: Devices | 826558 |
| June 1, 2012 | NAI | Medical Devices & Rad Health · Compliance: Devices | 784537 |
| May 17, 2012 | VAI | Medical Devices & Rad Health · Compliance: Devices | 782300 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bausch & Lomb Inc
Stock ticker
BLCO
Exchange
NYSE
Share price
$21.14
Market cap
$7.6B
Price as of
November 13, 2026
FEI Number
1920664
Address
3365 Tree Court Industrial Blvd, Saint Louis, Missouri 63122, United States
Country
United States
ID: 6e2d24ec-25b4-419c-ba74-db88dd714834